−10.63 MUSD
2.23 MUSD
2.91 M
About Ensysce Biosciences, Inc.
Sector
Industry
CEO
D. Lynn Kirkpatrick
Website
Headquarters
La Jolla
Founded
2003
ISIN
US2936024056
FIGI
BBG00JFF4174
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ENSC is 0.5499 USD — it has decreased by 5.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ensysce Biosciences, Inc. stocks are traded under the ticker ENSC.
Ensysce Biosciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ENSC stock is 14.62% volatile and has beta coefficient of 1.19. Check out the list of the most volatile stocks — is Ensysce Biosciences, Inc. there?
One year price forecast for Ensysce Biosciences, Inc. has a max estimate of 17.5000 USD and a min estimate of 17.5000 USD.
ENSC earnings for the last quarter are −0.98 USD per share, whereas the estimation was −1.85 USD resulting in a 47.12% surprise. The estimated earnings for the next quarter are −0.87 USD per share. See more details about Ensysce Biosciences, Inc. earnings.
Ensysce Biosciences, Inc. revenue for the last quarter amounts to 495.00 K USD despite the estimated figure of 760.00 K USD. In the next quarter revenue is expected to reach 395.00 K USD.
Yes, you can track Ensysce Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
ENSC stock has fallen by 26.68% compared to the previous week, the month change is a 33.75% fall, over the last year Ensysce Biosciences, Inc. has showed a 88.28% decrease.
ENSC net income for the last quarter is −3.50 M USD, while the quarter before that showed −2.23 M USD of net income which accounts for −56.99% change. Track more Ensysce Biosciences, Inc. financial stats to get the full picture.
Today Ensysce Biosciences, Inc. has the market capitalization of 1.83 M, it has decreased by 3.70% over the last week.
No, ENSC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENSC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ensysce Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ensysce Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ensysce Biosciences, Inc. stock shows the sell signal. See more of Ensysce Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Ensysce Biosciences, Inc. future price: according to them, ENSC price has a max estimate of 17.50 USD and a min estimate of 17.50 USD. Read a more detailed Ensysce Biosciences, Inc. forecast: see what analysts think of Ensysce Biosciences, Inc. and suggest that you do with its stocks.